Retroviral expression of either KRASG12D or NRASG12D alone did not induce leukemia or an identified MPD, yet both cooperated with RUNX1-RUNX1T1 to accelerate development of AML with NRAS serving as a more potent inducer of disease in this context. This evidence concerns the gene RUNX1 and leukemia.